Parkin Pleiotropy: Extremely Atypical Phenotypes in Patients With Compound Heterozygous Mutations
References
- 1Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392(6676): 605–8. DOI: 10.1038/33416
- 2Kasten M, Marras C, Klein C.
Nonmotor Signs in Genetic Forms of Parkinson’s Disease [Internet] . International Review of Neurobiology. 2017; 133: 129–178. Elsevier Inc. DOI: 10.1016/bs.irn.2017.05.030 - 3Elia AE, Sorbo F Del, Romito LM, Barzaghi C, Garavaglia B, Albanese A. Isolated limb dystonia as presenting feature of Parkin disease. J Neurol Neurosurg Psychiatry. 2014; 85(7): 827–8. DOI: 10.1136/jnnp-2013-307294
- 4Lohmann E, Periquet M, Bonifati V, Wood NW, De Michele G, Bonnet AM, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol. 2003; 54(2): 176–85. DOI: 10.1002/ana.10613
- 5Khan NL, Graham E, Critchley P, Schrag AE, Wood NW, Lees AJ, et al. Parkin disease: A phenotypic study of a large case series. Brain. 2003; 126(6): 1279–92. DOI: 10.1093/brain/awg142
- 6Erro R, Bhatia KP. Novel movement disorder society-Parkinson’s disease criteria: What about SWEDD and genetic forms? Mov Disord. 2016; 31(3): 431. DOI: 10.1002/mds.26538
- 7Abbruzzese G, Pigullo S, Schenone A, Bellone E, Marchese R, Di Maria E, et al. Does parkin play a role in the peripheral nervous system? A family report. Mov Disord. 2004; 19(8): 978–81. DOI: 10.1002/mds.20113
- 8Domingos J, Coelho T, Taipa R, Basto JP, Melo-Pires M, Magalhães MJ. PARK2 presenting as a disabling peripheral axonal neuropathy. Neurol Sci. 2015; 36(2): 341–3. DOI: 10.1007/s10072-014-1898-y
- 9Ohsawa Y, Kurokawa K, Sonoo M, Yamada H, Hemmi S, Iwatsuki K, et al. Reduced amplitude of the sural nerve sensory action potential in PARK2 patients. Neurology. 2005; 65(3): 459–62. DOI: 10.1212/01.wnl.0000171859.85078.3d
- 10Okuma Y, Hattori N, Mizuno Y. Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2). Park Relat Disord. 2003; 9(5): 313–4. DOI: 10.1016/S1353-8020(02)00114-1
- 11Barbeau A. The pathogenesis of Parkinson’s disease: A new hypothesis. Can Med Assoc J. 1962; 87: 802–7.
- 12Schneider SA, Alcalay RN. Neuropathology of Genetic Synucleinopathies with Parkinsonism – review of the literature. Mov Disord. 2018; 32(11): 1504–23. DOI: 10.1002/mds.27193
- 13Benbunan BR, Korczyn AD, Giladi N. Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson’s disease. J Neural Transm. 2004; 111(1): 47–57. DOI: 10.1007/s00702-003-0079-6
- 14Isaacs D, Claassen D, Bowman AB, Hedera P. Phenotypic discordance in siblings with identical compound heterozygous PARK2 mutations. Brain Sci. 2017; 7(7): 9–12. DOI: 10.3390/brainsci7070071
DOI: https://doi.org/10.5334/tohm.55 | Journal eISSN: 2160-8288
Language: English
Submitted on: Apr 6, 2020
Accepted on: Jun 27, 2020
Published on: Aug 13, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Patricio Millar Vernetti, Malco Rossi, Marcelo Merello, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.